Collagenous retinopathy is a progressive eye disease caused by systemic damage to the connective tissue, in which all structures of the choroid and retina are involved in the pathological process. Retinopathy is characterized by a progressive nature of its course, the presence of characteristic changes in the fundus, the absence of an inflammatory response, and a tendency to recur.
The reasons for the development of the disease are not fully understood. Most often, collagenous retinopathy is associated with systemic collagenopathy caused by autoimmune mechanisms.
When examining patients with suspected collagenous retinopathy, it is necessary to conduct a complete ophthalmological examination, including visometry, refractometry and biomicroscopy (ophthalmoscopy). In addition, for differential diagnosis with other diseases of the retina and vascular tract, it is necessary to perform angiography, electrophysiological studies and computed tomography.
Treatment of collagenous retinopathy is complex and includes the use of medications that affect the metabolism of connective tissue (corticosteroids, calcium supplements), as well as the use of antiviral and antibacterial agents. In some cases, surgical treatment may be required to eliminate newly formed vessels.
The prognosis of collagenous retinopathy depends on the form of the disease and the severity of damage to the fundus. With timely treatment and compliance with the doctor’s recommendations, it is possible to preserve vision in most patients.